This inventor holds 1 USPTO granted patent. Top assignee: South African Inventions Development Corporation. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: John F Newman: Innovator in Immunization Technology
Introduction
John F Newman is a notable inventor based in Makhanda, South Africa. He has made significant contributions to the field of immunization through his innovative work. His research focuses on developing effective immunizing agents that can enhance the immune response in animals.
Latest Patents
John F Newman holds a patent for an invention titled "Adjuvant for Immunization." This invention provides an immunizing agent or preparation, such as a vaccine for parenteral administration. It comprises particles of coalesced and covalently interlinked physiologically compatible proteinaceous molecules. Entrapped within these particles is an immunogen that is designed to be released gradually through proteolysis. When released, the immunogen is of sufficient size to elicit an immune response to its characteristic immunogenic determinants. The proteinaceous molecules are preferably homotypic for the animal to be immunized, and the particles or molecules carrying the immunogenic determinants are crosslinked to the proteinaceous molecules.
Career Highlights
John F Newman has dedicated his career to advancing immunization technologies. His work has been recognized for its potential to improve vaccine efficacy and safety. He is associated with the South African Inventions Development Corporation, where he continues to innovate in the field of immunology.
Collaborations
John F Newman has collaborated with Donald A Hendry, contributing to the development of immunization technologies. Their partnership has focused on enhancing the effectiveness of vaccines through innovative approaches.
Conclusion
John F Newman is a pioneering inventor whose work in immunization technology has the potential to make a significant impact on public health. His innovative patent demonstrates a commitment to advancing vaccine development and improving immune responses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile